Correlation Between Dow Jones and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Dow Jones and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dow Jones and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dow Jones Industrial and Moleculin Biotech, you can compare the effects of market volatilities on Dow Jones and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dow Jones with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dow Jones and Moleculin Biotech.
Diversification Opportunities for Dow Jones and Moleculin Biotech
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dow and Moleculin is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Dow Jones Industrial and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Dow Jones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dow Jones Industrial are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Dow Jones i.e., Dow Jones and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Dow Jones and Moleculin Biotech
Assuming the 90 days trading horizon Dow Jones is expected to generate 2.54 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, Dow Jones Industrial is 6.96 times less risky than Moleculin Biotech. It trades about 0.21 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 254.00 in Moleculin Biotech on August 25, 2024 and sell it today you would earn a total of 19.00 from holding Moleculin Biotech or generate 7.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Dow Jones Industrial vs. Moleculin Biotech
Performance |
| Timeline |
Dow Jones and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Dow Jones Industrial
Pair trading matchups for Dow Jones
Moleculin Biotech
Pair trading matchups for Moleculin Biotech
Pair Trading with Dow Jones and Moleculin Biotech
The main advantage of trading using opposite Dow Jones and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dow Jones position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Dow Jones vs. Vistra Energy Corp | Dow Jones vs. Fluence Energy | Dow Jones vs. Old Republic International | Dow Jones vs. Empresa Distribuidora y |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |